About the PHIBER
This is a brief summary. This is now part of an exciting NIH multi-institutional program, the AIM-AHEAD Program, and it is connected with a lot more goingt on and coming soon from public and private organizations aware of the problems in our public health and committed to making things Better for All.
Contact us to learn more, since the documentation for public release is still being worked on. Ypou can read this summary:
PHIBER (PHEBR) Summary, April 2022
The Population Health Informatics Biomedical Equity Resource (PHIBER) is a key tool for developing
understanding of neurophysiological turbulence and entanglement leading to dysautonomic,
autoimmune, arrhythmic pathologies and also pleasure/pain dysfunctions.
This resource constitutes an Inteligence Information Domain (IID) in the contextual framework of the
OASIS architecture and its implementations. The PHIBER includes:
- diagnostic history data of several types (e.g., EKG, echocardiography, and pertinent other imaging
and recording, as well as histories of hypertension, temperature flux and arrhythmia, equilibrium
and balance episodes, and other quantitative and qualitative parameters over life-history, as much
as possible)
- patient and family behavioral and lifestyle data (both specific, as known and accessible, and
through computational inferences) such as nutrition, exercise and fitness, exposure to and
ingestion of toxins and stressors of chemical nature (e.g., air, water, food) and particularly
psychological and social stress (e.g., abuse, anxiety, depression, trauma, PTSD).
- Research and clinical studies, globally, provide the rock-solid basis for the assertion that what are termed
neuroelectrochemical stressors – within the range of sources indicated above – are a major contributing
factor – even beyond genetic factors – leading to subsequent disorders and diseases of the types indicated
above. These pathologies commence particularly in adolescence and middle age and the outcomes are
almost universally of only two types:
- extraordinary complications, disabilities and comorbidities, reducing the potentials for a normal
lifestyle (including employment and a professional life) and for an average-length lifespan
- early and often sudden death